Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia

NCT02010957 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
85
Enrollment
OTHER
Sponsor class

Stopped Stop of tracer production by company, unavailability of 123I Iodometomidate at most study centers, slow recruitment

Conditions

Interventions

Sponsor

Wuerzburg University Hospital

Collaborators